BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $84 | $88 | $105 | $105 |
| Short-Term Investments | $129 | $172 | $190 | $216 |
| Receivables | $91 | $91 | $93 | $79 |
| Inventory | $5 | $5 | $7 | $8 |
| Other Curr. Assets | $46 | $42 | $14 | $14 |
| Total Curr. Assets | $356 | $398 | $410 | $422 |
| Property Plant & Equip (Net) | $19 | $20 | $20 | $20 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $40 | $10 | $22 | $22 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $32 | $29 | $29 | $27 |
| Total NC Assets | $91 | $59 | $70 | $68 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $446 | $457 | $480 | $490 |
| Liabilities | – | – | – | – |
| Payables | $6 | $9 | $10 | $12 |
| Short-Term Debt | $39 | $2 | $37 | $35 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $145 | $167 | $93 | $113 |
| Total Curr. Liab. | $190 | $177 | $140 | $160 |
| LT Debt | $644 | $701 | $792 | $806 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $644 | $702 | $792 | $806 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $13 | $10 | $10 |
| Total Liabilities | $834 | $879 | $932 | $966 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$1,752 | -$1,765 | -$1,770 | -$1,770 |
| AOCI | $1 | $2 | $1 | $1 |
| Other Equity | $1,361 | $1,340 | $1,315 | $1,291 |
| Total Equity | -$388 | -$422 | -$452 | -$476 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $446 | $457 | $480 | $490 |
| Net Debt | $599 | $615 | $724 | $736 |